PDS Biotechnology CorporationPDSBNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank62
3Y CAGR-8.2%
5Y CAGR+16.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-8.2%/yr
vs +83.9%/yr prior
5Y CAGR
+16.7%/yr
Recent deceleration
Acceleration
-92.1pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $32.21M | -11.2% |
| 2024 | $36.26M | -15.8% |
| 2023 | $43.05M | +3.3% |
| 2022 | $41.67M | +94.4% |
| 2021 | $21.44M | +43.9% |
| 2020 | $14.90M | -3.3% |
| 2019 | $15.41M | +322.7% |
| 2018 | $3.65M | -93.0% |
| 2017 | $51.97M | +31.5% |
| 2016 | $39.51M | - |